Bright Minds Announces Effective Date of Share Consolidation

Press Release

Vancouver, British Columbia, July 11, 2023 – Bright Minds Biosciences Inc. (CSE:DRUG) (NASDAQ:DRUG) (“Bright Minds” or the “Company”), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain,announces that, further to its news release on June 22, 2023, the Company will consolidate its common shares (the “CommonShares”)…

Bright Minds Announces Proposed Share Consolidation

Press Release

Vancouver, British Columbia, June22, 2023 – Bright Minds Biosciences Inc. (CSE:DRUG) (NASDAQ:DRUG) (“Bright Minds” or the “Company”), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain,announces thatit intends to consolidate its common shares (the “Common shares”) on a five (5) to one (1) basis (the “Consolidation”).…